Updated Treatment Selectors (by therapeutic indication) are now available in the Prescribing Resources section of the website.
This has been a major update as one new antiretroviral (doravirine) and four new antiretroviral combinations (atazanavir/cobicistat, darunavir/cobicistat, bictegravir/emtricitabine/tenofovir alafenamide, emtricitabine/tenofovir alafenamide) are now included, along with some new comedications.
In order to include the additional ARVs and maintain the single sheet format, abacavir has been removed and emtricabine (FTC) and lamivudine (3TC) have been combined into a single column (due their similar interaction profiles), though where interactions differ this has been indicated and details given in a footnote.
